A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Suman Kambhampati, MD MBBS
Kansas City VA Medical Center, Kansas City, MO
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- San Francisco Va Medical Center, San Francisco, Ca
San Francisco, California, United States
Recruiting - Kansas City Va Medical Center, Kansas City, Mo
Kansas City, Missouri, United States
Suman Kambhampati, MD MBBSRecruiting - Durham Va Medical Center, Durham, Nc
Durham, North Carolina, United States
Recruiting - Va Puget Sound Health Care System Seattle Division, Seattle, Wa
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2025
- Primary completion
- 30 Jun 2030
- Completion
- 31 Dec 2030
- Last update posted
- 14 Oct 2025
- Registered enrollment
- 100
- Registry id
- NCT06520098
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.